Cardima, Inc. (CADM) - Product Pipeline Analysis

GlobalData, October 2011, Pages: 28

Cardima, Inc. (CADM) - Product Pipeline Analysis

Summary

Cardima, Inc. (Cardima) designs, develops, manufactures and markets minimally invasive, single-use, micro-catheter systems for the mapping and ablation of the two most common forms of cardiac arrhythmias: atrial fibrillation and ventricular tachycardia. Its therapeutic products include Revelation, a mapping catheter; micro-catheter system for mapping left and right atria; Revelation T- flex, a micro catheter system with tissue temperature sensors used in creating and mapping linear, thin, long, and continuous and transmural lesions in the atrium. The company operates in two distinct market segments: Electrophysiology (EP) and Cardiac Surgery. Cardima, Inc.

This report is a source for data, analysis and actionable intelligence on the Cardima, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
Key Facts
Cardima, Inc. - Major Products and Services
Cardima, Inc. Pipeline Products by Equipment Type
Cardima, Inc. Pipeline Products by Development Stage
Cardima, Inc. Pipeline Products by Trial Phase
CADENCE EPL
Product Status
Product Description
EP Ablation System
Product Status
Product Description
Product Milestone
EP Ablation System Clinical Trial
Product Patent Details
New Energy Management Device
Product Status
Product Description
Product Patent Details
Revelation - INTELLITEMP EP
Product Status
Product Description
Revelation Helix
Product Status
Product Description
Product Milestone
Revelation Helix Clinical Trial
Product Patent Details
Revelation Helix STX
Product Status
Product Description
Product Milestone
Product Patent Details
Revelation Tx
Product Status
Product Description
Product Milestone
Revelation Tx Clinical Trial
Cardima, Inc. - Key Competitors
Cardima, Inc. - Key Employees
Cardima, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Mar 29, 2010: Cardima Receives CE Mark For Surgical Ablation System
Mar 18, 2010: Cardima Applies For Listing On NASDAQ Stock Market
Mar 01, 2010: Cardima Appoints Dr. Peter Wong To Its Board
Jan 04, 2010: Cardima Gets Marketing Approval For Pathfinder Diagnostic Catheters
Jan 04, 2010: Cardima Receives Marketing Approval For Pathfinder Diagnostic Catheters
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Cardima, Inc., Key Facts
Cardima, Inc. Key Pipeline Products by Equipment Type
Cardima, Inc. Key Pipeline Products by Therapy Area
Cardima, Inc. Key Pipeline Products by Development Stage
Cardima, Inc. Key Pipeline Products by Trial Phase
Cardima, Inc., Key Facts
Cardima, Inc., Major Products and Services
Cardima, Inc. Number of Pipeline Products by Equipment Type
Cardima, Inc. Pipeline Products by Equipment Type
Cardima, Inc. Number of Pipeline Products by Development Stage
Cardima, Inc. Pipeline Products by Development Stage
Cardima, Inc. Number of Pipeline Products by Trial Phase
Cardima, Inc. Pipeline Products by Trial Phase
CADENCE EPL - Product Status
CADENCE EPL - Product Description
EP Ablation System - Product Status
EP Ablation System - Product Description
EP Ablation System - Product Milestone
EP Ablation System - Evaluation Of The Cardima EP Ablation System for Atrial Fibrillation
EP Ablation System - Hybrid Therapy With Right Atrial Catheter Ablation And Previously Ineffective Antiarrhythmic Drugs For The Management Of Atrial Fibrillation
EP Ablation System - Right Atrial Mapping And Linear Ablation For Paroxysmal Atrial Fibrillation
EP Ablation System - Patent Details
New Energy Management Device - Product Status
New Energy Management Device - Product Description
New Energy Management Device - Patent Details
Revelation - INTELLITEMP EP - Product Status
Revelation - INTELLITEMP EP - Product Description
Revelation Helix - Product Status
Revelation Helix - Product Description
Revelation Helix - Product Milestone
Revelation Helix - Mapping And Ablation In The Pulmonary Veins Using The REVELATION Helix Microcatheter
Revelation Helix - Patent Details
Revelation Helix STX - Product Status
Revelation Helix STX - Product Description
Revelation Helix STX - Product Milestone
Revelation Helix STX - Patent Details
Revelation Tx - Product Status
Revelation Tx - Product Description
Revelation Tx - Product Milestone
Revelation Tx - The REVELATION Tx Microcatheter Ablation System Clinical Trial
Revelation Tx - Right Atrial Mapping And Linear Ablation For Paroxysmal Atrial Fibrillation
Cardima, Inc., Key Employees

List of Figures
Cardima, Inc. Pipeline Products by Equipment Type
Cardima, Inc. Pipeline Products by Development Stage
Cardima, Inc. Pipeline Products by Trial Phase

Arbor Surgical Technologies, Inc.
Bard Peripheral Vascular OEM Products
BioVentrix
Cardica, Inc.
CardioPolymers, Inc.
CEREMED, INC.
Boston Scientific Corporation
Medtronic, Inc.

Customers who bought this item also bought

• The Boeing Company-Competitive Benchmarking Analysis
• Northrop Grumman Corporation-Competitive Benchmarking Analysis
• TRW Automotive Holdings Corp. (TRW) - Financial and Strategic SWOT Analysis Review
• General Dynamics Corporation-Competitive Benchmarking Analysis
• Lockheed Martin Corporation-Competitive Benchmarking Analysis
• Tan Chong Motor Holdings Berhad (TCHONG) - Financial and Strategic SWOT Analysis Review
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• CarMax Inc